Staff Report with Final Results: Texas State Board of Pharmacy Page: A3
70 p.View a full description of this report.
Extracted Text
The following text was automatically extracted from the image on this page using optical character recognition software:
Provisions Added by the Legislature
Prescription Monitoring Program - The legislature added several provisions to H.B. 2561 to further
improve the use and effectiveness of the Prescription Monitoring Program. The changes impact not only
pharmacists and the pharmacy board, but also other prescribers and licensing boards. The description
below discusses changes directly impacting the pharmacy board, while other changes impacting prescribers
and their licensing boards are summarized in the Sunset Commission's separate materials on each of
those agencies.
" Require prescriber licensing agencies, including the medical, nursing, podiatric, dental, veterinary,
and optometry boards, to provide licensee information to the pharmacy board, and require the
pharmacy board to use this information to automatically register practitioners to use the Prescription
Monitoring Program.
" Require a joint interim study of changes to the Prescription Monitoring Program, to include the
extent of drug diversion by animal owners, by January 1, 2019 to understand the impacts of the
PMP on controlled substance abuse and guide potential future changes.
Remote dispensing site license - Require the board to create a remote dispensing site license for
pharmacies in rural or medically underserved areas to provide telepharmacy services.
Religious freedom - Prohibit rulemaking that would violate religious freedom protections in Chapter
110, Civil Practice and Remedies Code.
Prescription drug donation program - Require the Executive Commissioner of the Health and
Human Services Commission to adopt standards for a donation and redistribution program for unused
prescription drugs.
Texas A&M College of Pharmacy - Require that the Texas A&M College of Pharmacy be located
in Kleburg county and include "Irma Rangel" in its official name.
Fiscal Implication Summary
Overall, the Sunset Commission's recommendations as enacted in H.B. 2561 will not have a significant
fiscal impact to the state. Based on the contingency rider and fiscal note for H.B. 2561, changes to the
Prescription Monitoring Program will cost $399,466 in General Revenue in fiscal years 2018-2019,
which will be offset by increased fee revenue as required by state law. These costs include one full-time
employee to carry out the bill's Prescription Monitoring Program provisions. Also, while the bill's required
reduction in late fees for pharmacy technicians will reduce fee revenue by approximately $36,000 per
year, this reduction will not cause a significant overall impact.Texas State Board of Pharmacy Staff Report with Final Results
Final ResultsA3
Sunset Advisory Commission
June 2017
Upcoming Pages
Here’s what’s next.
Search Inside
This report can be searched. Note: Results may vary based on the legibility of text within the document.
Tools / Downloads
Get a copy of this page or view the extracted text.
Citing and Sharing
Basic information for referencing this web page. We also provide extended guidance on usage rights, references, copying or embedding.
Reference the current page of this Report.
Ogle, Steven; Schiff, Tamara; Hartley, Cee & Teleki, Katharine. Staff Report with Final Results: Texas State Board of Pharmacy, report, June 2017; Austin, Texas. (https://texashistory.unt.edu/ark:/67531/metapth1033475/m1/11/: accessed July 17, 2024), University of North Texas Libraries, The Portal to Texas History, https://texashistory.unt.edu.; crediting UNT Libraries Government Documents Department.